Cargando…

Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer

BACKGROUND: Colorectal cancer is one of the most important causes of morbidity and mortality in the world. It has been suggested that tissue inhibitor of metalloproteinase-1 (TIMP-1) plays a particular role in cancer promotion. The objective of the present study was to compare the effect of repeated...

Descripción completa

Detalles Bibliográficos
Autores principales: Roayaei, Mahnaz, Emami, Hamid, Adeli, Pouria, Rezaei, Abbas, Akbari, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333519/
https://www.ncbi.nlm.nih.gov/pubmed/25709652
_version_ 1782358050389098496
author Roayaei, Mahnaz
Emami, Hamid
Adeli, Pouria
Rezaei, Abbas
Akbari, Mojtaba
author_facet Roayaei, Mahnaz
Emami, Hamid
Adeli, Pouria
Rezaei, Abbas
Akbari, Mojtaba
author_sort Roayaei, Mahnaz
collection PubMed
description BACKGROUND: Colorectal cancer is one of the most important causes of morbidity and mortality in the world. It has been suggested that tissue inhibitor of metalloproteinase-1 (TIMP-1) plays a particular role in cancer promotion. The objective of the present study was to compare the effect of repeated measurement of carcinoembryonic antigen (CEA) and TIMP-1 plasma levels in a follow-up response to chemotherapy treatment in patients with unresectable metastatic colorectal cancer by surgery. MATERIALS AND METHODS: All consecutive patients between 18 and 75 years old in both genders with rectal adenocarcinoma who referred to Sayed Al-Shohada Medical Center, during 6 months of study period enrolled in the study. Level of CEA and TIMP-1 were assessed before and after two cycles of chemotherapy. Furthermore, patients underwent computed tomography scan to assess response to chemotherapy. The sensitivity, specificity, and areas under the receiver operating characteristic curves (AUC) calculated for baseline level of CEA and TIMP. RESULTS: The mean age of the studied patients was 52.7 ± 7.5 years, 12 patients (48%) were male. Response to chemotherapy after two cycles was 80%. In patients who responded to chemotherapy level of TIMP after treatment was significantly decreased compared to before treatment (P < 0.0001). Before and after treatment in patients who responded to chemotherapy the level of TIMP was significantly lower than who did not response to chemotherapy (P < 0.05). The critical values for the prediction response to chemotherapy for CEA was >63 (AUC: 0.54) and for TIMP was ≤8823 (AUC: 0.68). CONCLUSION: The present study has identified a strong significant association between high plasma TIMP-1 levels and short survival in patients with colorectal cancer. In addition, results demonstrated that the TIMP-1 provides stronger prognostic information than CEA.
format Online
Article
Text
id pubmed-4333519
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43335192015-02-23 Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer Roayaei, Mahnaz Emami, Hamid Adeli, Pouria Rezaei, Abbas Akbari, Mojtaba J Res Med Sci Original Article BACKGROUND: Colorectal cancer is one of the most important causes of morbidity and mortality in the world. It has been suggested that tissue inhibitor of metalloproteinase-1 (TIMP-1) plays a particular role in cancer promotion. The objective of the present study was to compare the effect of repeated measurement of carcinoembryonic antigen (CEA) and TIMP-1 plasma levels in a follow-up response to chemotherapy treatment in patients with unresectable metastatic colorectal cancer by surgery. MATERIALS AND METHODS: All consecutive patients between 18 and 75 years old in both genders with rectal adenocarcinoma who referred to Sayed Al-Shohada Medical Center, during 6 months of study period enrolled in the study. Level of CEA and TIMP-1 were assessed before and after two cycles of chemotherapy. Furthermore, patients underwent computed tomography scan to assess response to chemotherapy. The sensitivity, specificity, and areas under the receiver operating characteristic curves (AUC) calculated for baseline level of CEA and TIMP. RESULTS: The mean age of the studied patients was 52.7 ± 7.5 years, 12 patients (48%) were male. Response to chemotherapy after two cycles was 80%. In patients who responded to chemotherapy level of TIMP after treatment was significantly decreased compared to before treatment (P < 0.0001). Before and after treatment in patients who responded to chemotherapy the level of TIMP was significantly lower than who did not response to chemotherapy (P < 0.05). The critical values for the prediction response to chemotherapy for CEA was >63 (AUC: 0.54) and for TIMP was ≤8823 (AUC: 0.68). CONCLUSION: The present study has identified a strong significant association between high plasma TIMP-1 levels and short survival in patients with colorectal cancer. In addition, results demonstrated that the TIMP-1 provides stronger prognostic information than CEA. Medknow Publications & Media Pvt Ltd 2014-12 /pmc/articles/PMC4333519/ /pubmed/25709652 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Roayaei, Mahnaz
Emami, Hamid
Adeli, Pouria
Rezaei, Abbas
Akbari, Mojtaba
Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
title Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
title_full Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
title_fullStr Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
title_full_unstemmed Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
title_short Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
title_sort predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333519/
https://www.ncbi.nlm.nih.gov/pubmed/25709652
work_keys_str_mv AT roayaeimahnaz predictivevalueoftissueinhibitorofmetalloproteinases1andcarcinoembryonicantigenplasmalevelsinresponsetochemotherapyinpatientswithmetastaticcolorectalcancer
AT emamihamid predictivevalueoftissueinhibitorofmetalloproteinases1andcarcinoembryonicantigenplasmalevelsinresponsetochemotherapyinpatientswithmetastaticcolorectalcancer
AT adelipouria predictivevalueoftissueinhibitorofmetalloproteinases1andcarcinoembryonicantigenplasmalevelsinresponsetochemotherapyinpatientswithmetastaticcolorectalcancer
AT rezaeiabbas predictivevalueoftissueinhibitorofmetalloproteinases1andcarcinoembryonicantigenplasmalevelsinresponsetochemotherapyinpatientswithmetastaticcolorectalcancer
AT akbarimojtaba predictivevalueoftissueinhibitorofmetalloproteinases1andcarcinoembryonicantigenplasmalevelsinresponsetochemotherapyinpatientswithmetastaticcolorectalcancer